Filing Details
- Accession Number:
- 0001123292-20-000110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 17:13:27
- Reporting Period:
- 2020-01-04
- Accepted Time:
- 2020-01-07 17:13:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356090 | Intrexon Corp | XON | Services-Commercial Physical & Biological Research (8731) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1724195 | Helen Sabzevari | 20374 Seneca Meadows Parkway Germantown MD 20876 | President And Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-04 | 17,667 | $0.00 | 104,734 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-06 | 6,732 | $5.83 | 98,002 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2020-01-04 | 17,667 | $0.00 | 17,667 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2020-01-05 | 500,000 | $0.00 | 500,000 | $0.00 |
| Common Stock | Option to Purchase Common Stock (Right to Buy) | Acquisiton | 2020-01-05 | 1,500,000 | $0.00 | 1,500,000 | $5.95 |
| Common Stock | Option to Purchase Common Stock (Right to Buy) | Acquisiton | 2020-01-05 | 1,500,000 | $0.00 | 1,500,000 | $11.90 |
| Common Stock | Option to Purchase Common Stock (Right to Buy) | Acquisiton | 2020-01-05 | 1,500,000 | $0.00 | 1,500,000 | $17.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 52,999 | No | 4 | M | Direct | ||
| 500,000 | No | 4 | A | Direct | ||
| 1,500,000 | 2030-01-05 | No | 4 | A | Direct | |
| 1,500,000 | 2030-01-05 | No | 4 | A | Direct | |
| 1,500,000 | 2030-01-05 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- The restricted stock units were granted on January 4, 2019 and January 25, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022, and 2023.
- The restricted stock units vest in full on January 5, 2021.
- The option vests in four installments as follows: 50% on January 5, 2021, and the remaining 50% in three equal annual installments on each of January 5, 2022, 2023, and 2024.
- The option vests in four equal annual installments beginning on January 5, 2021.
Billionaire Hedge Funds
